Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8(+) T cells and exhibit a distinct CD95(hi) B cell phenotype
However, in several Phase III trials, Rituximab failed to meet its primary efficacy endpoints
Protein timing: Protein timing is another important factor in supporting proper protein metabolism
HYDROXO-B12 Injection HYDROXO-B12 Injection is used for the prophylaxis and treatment of pernicious (Addisonian) anemia and other macrocytic anemias associated with vitamin B12 deficiency
127 Fructose metabolism Fructose metabolism, particularly through the aldolase reductase pathway in the liver, results in increased UA levels
Bosoi CR, Parent-Robitaille C, Anderson K, Tremblay M, Rose CF